Verônica F Parreira1, Tania Janaudis-Ferreira2, Rachel A Evans3, Sunita Mathur4, Roger S Goldstein5, Dina Brooks6. 1. Department of Physical Therapy, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; CAPES Brazil, West Park Healthcare Centre (Respiratory Medicine), Department of Physical Therapy, University of Toronto, Toronto, ON, Canada; Department of Respiratory Medicine, West Park Healthcare Centre, Toronto, ON, Canada; Sunnybrook Health Sciences Centre, St. John's Rehabilitation Program, Sunnybrook Research Institute, Toronto, ON, Canada. 2. Sunnybrook Health Sciences Centre, St. John's Rehabilitation Program, Sunnybrook Research Institute, Toronto, ON, Canada; Department of Physical Therapy, University of Toronto, Toronto, ON, Canada; Department of Infection, Immunity and Inflammation, School of Medicine, University of Leicester, Leicester, England. 3. Department of Medicine, University of Toronto, Toronto, ON, Canada. 4. Sunnybrook Health Sciences Centre, St. John's Rehabilitation Program, Sunnybrook Research Institute, Toronto, ON, Canada; Department of Infection, Immunity and Inflammation, School of Medicine, University of Leicester, Leicester, England. 5. Sunnybrook Health Sciences Centre, St. John's Rehabilitation Program, Sunnybrook Research Institute, Toronto, ON, Canada; Department of Infection, Immunity and Inflammation, School of Medicine, University of Leicester, Leicester, England; Department of Medicine, University of Toronto, Toronto, ON, Canada. 6. Sunnybrook Health Sciences Centre, St. John's Rehabilitation Program, Sunnybrook Research Institute, Toronto, ON, Canada; Department of Infection, Immunity and Inflammation, School of Medicine, University of Leicester, Leicester, England. Electronic address: dina.brooks@utoronto.ca.
Abstract
Background: The incremental shuttle walk test (ISWT) was developed > 20 years ago and has been used to assess peak exercise capacity in a variety of chronic diseases. The aim of this systematic review is to describe the measurement properties of the ISWT in a clinical population. Methods: Of 800 articles identified by electronic and hand searches, 35 were included. Twenty-one articles included data on the validity of the ISWT, 18 on the reliability, four on the responsiveness,and four on the interpretability. Results: Most of the studies were conducted in patients with COPD (n = 13) or cardiac disease(n = 8). For criterion validity, comparisons between distance covered during the ISWT and peak oxygen consumption reported correlations ranging from 0.67 to 0.95 ( P <.01). Intraclass correlation coefficients for test-retest reliability ranged from 0.76 to 0.99. The ISWT was shown to be responsive to pulmonary rehabilitation and bronchodilator administration. The minimal clinically important difference (MCID) in patients with COPD was 48 m. Predictive equations for the distance in the ISWT are available for healthy individuals.Conclusions: The ISWT can be considered a valid and reliable test to assess maximal exercise capacity in individuals with chronic respiratory diseases. The ISWT has been shown to be responsive to pulmonary rehabilitation and bronchodilator use in individuals with COPD, cystic fibrosis,and asthma. Further studies examining responsiveness and the MCID of the ISWT in patients with conditions other than lung diseases are required for the interpretation of interventions in other populations.
Background: The incremental shuttle walk test (ISWT) was developed > 20 years ago and has been used to assess peak exercise capacity in a variety of chronic diseases. The aim of this systematic review is to describe the measurement properties of the ISWT in a clinical population. Methods: Of 800 articles identified by electronic and hand searches, 35 were included. Twenty-one articles included data on the validity of the ISWT, 18 on the reliability, four on the responsiveness,and four on the interpretability. Results: Most of the studies were conducted in patients with COPD (n = 13) or cardiac disease(n = 8). For criterion validity, comparisons between distance covered during the ISWT and peak oxygen consumption reported correlations ranging from 0.67 to 0.95 ( P <.01). Intraclass correlation coefficients for test-retest reliability ranged from 0.76 to 0.99. The ISWT was shown to be responsive to pulmonary rehabilitation and bronchodilator administration. The minimal clinically important difference (MCID) in patients with COPD was 48 m. Predictive equations for the distance in the ISWT are available for healthy individuals.Conclusions: The ISWT can be considered a valid and reliable test to assess maximal exercise capacity in individuals with chronic respiratory diseases. The ISWT has been shown to be responsive to pulmonary rehabilitation and bronchodilator use in individuals with COPD, cystic fibrosis,and asthma. Further studies examining responsiveness and the MCID of the ISWT in patients with conditions other than lung diseases are required for the interpretation of interventions in other populations.
Authors: Gaëtane C Michaud; Colleen L Channick; Chad R Marion; Robert M Tighe; James A Town; Andrew M Luks; Jeremy B Richards; Sucharita Kher; Prerna Mota; Gina Hong; Natalie E West; Craig Rackley; Luke Neilans; Josanna Rodriguez-Lopez; Hilary DuBrock; Cassie C Kennedy; Diana J Kelm; Carey C Thomson Journal: Ann Am Thorac Soc Date: 2015-09
Authors: Eun Jae Ko; Jang Ho Lee; Hyang Yi Lee; Seong Ho Lee; Hack-Jae Lee; Ganghee Chae; Sei Won Lee; Seung Won Ra Journal: J Pers Med Date: 2022-05-30
Authors: M E Major; R Kwakman; M E Kho; B Connolly; D McWilliams; L Denehy; S Hanekom; S Patman; R Gosselink; C Jones; F Nollet; D M Needham; R H H Engelbert; M van der Schaaf Journal: Crit Care Date: 2016-10-29 Impact factor: 9.097
Authors: Shaza Abo; David Ritchie; Linda Denehy; Yvonne Panek-Hudson; Louis Irving; Catherine L Granger Journal: Bone Marrow Transplant Date: 2021-07-16 Impact factor: 5.174